1. A medicament comprising the recombinant mistletoe lectin for the treatment of metastatic tumors, or skin cancer, wherein the recombinant mistletoe lectin is selected from the group of amino acid sequences SEQ ID № 1-12, or comprises part of, or is a fragment or their kombinatsiey.2. A medicament according to claim 1, wherein the recombinant mistletoe lectin polypeptide is the A chain of mistletoe lectin selected from the group of amino acids SEQ ID № 1-3, or comprises parts or fragments, or is their kombinatsiey.3. A medicament according to claim 1, wherein the recombinant mistletoe lectin polypeptide is the B chain of mistletoe lectin selected from the group of amino acids SEQ ID № 4-12, or comprises parts or fragments, or is their kombinatsiey.4. A medicament according to any one of claims 1-3, characterized in that the metastatic tumor or a skin cancer is malignant melanomoy.5. A medicament according to claim 1, wherein the drug is selected in cases where the standard antitumor therapy is futile or unfavorable outcome lecheniya.6. A medicament according to claim 1, wherein the drug is selected for treatment stages III and IV tumors or metastatic skin cancer, in particular malignant melanomy.7. A medicament according to claim 1, characterized in that the medicament is used after the first standard treatment opuholey.8. A medicament according to claim 1 optionally in combination with pharmaceutically compatible nositelem.9. A medicament according to claim 1, comprising the recombinant mistletoe lectin for a specific treatment of malignant1. Лекарственное средство, содержащее рекомбинантный лектин омелы, для лечения метастатических опухолей или рака кожи, отличающееся тем, что рекомбинантный лектин омелы выбран из группы аминокислотных последовательностей SEQ ID № 1-12 или содержит их части или фрагменты или является их комбинацией.2. Лекарственное средство по п.1, отличающееся тем, что рекомбинантный полипептид лектина омелы является А-цепью лектина омелы, выбра
